Actively Recruiting
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Led by Institute of Health Information and Statistics of the Czech Republic · Updated on 2026-03-27
1440
Participants Needed
5
Research Sites
8 weeks
Total Duration
On this page
Sponsors
I
Institute of Health Information and Statistics of the Czech Republic
Lead Sponsor
V
Vascular surgery, University hospital Královské Vinohrady, Prague
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research investigates the early detection of skin tumors using telemedicine tools in primary care settings across the Czech Republic. It is a national, prospective, multicenter, single-arm interventional pilot project involving general practitioners and dermatology centers. The study aims to improve healthcare efficiency by methodically preparing, implementing, and evaluating a new procedure for early skin tumor detection and integrating it into the healthcare system. Participants will be screened in general practitioners' offices where physicians are trained to examine skin lesions using magnifying devices like dermatoscopes and advanced telemedicine software supported by AI algorithms. High-risk lesions identified through this process will lead to referrals to specialized dermatology centers for further examination, including possible excision and histopathological assessment. The project includes collaboration between general practitioners and dermatologists and proposes systemic changes to enhance screening efficiency. Participants will have skin lesions examined with high-resolution imaging and telemedicine assessments. Researchers will measure potential malignancies from enrollment through baseline examination, confirmed malignancies at three months, and confirmed malignancies by histology at six months. The study involves approximately 1,440 individuals aged 50 and older, with ongoing monitoring and secure information exchange between healthcare providers. The total participation timeline includes baseline and follow-up diagnostic evaluations extending up to six months.
CONDITIONS
Brief Title
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant must have at least one suspected skin lesion
- Participant must have skin phototype I or phototype II
You will not qualify if you...
- Skin lesion examination by a dermatologist within the last 12 months
- Lack of signed consent to participate and consent for processing personal data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 6 months
Participants undergo examination of suspected skin lesions using dermatoscopes and telemedicine software at general practitioners' offices. High-risk lesions are identified and referred to dermatology centers for further assessment.
1 to 2 visits depending on lesion risk and referral requirements
Trial Site Locations
Total: 5 locations
1
St. Anne's University Hospital Brno
Brno, Czechia
Not Yet Recruiting
2
Olomouc University Hospital
Olomouc, Czechia
Actively Recruiting
3
University Hospital Pilsen
Pilsen, Czechia
Not Yet Recruiting
4
Bulovka University Hospital
Prague, Czechia
Actively Recruiting
5
University hospital Kralovske Vinohrady
Prague, Czechia
Not Yet Recruiting
Research Team
D
Dagmar Obšilová, Msc
L
Lucie Mandelova, Ph.D.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here